Inventor
LI DERUN
US31 patents
⚠️ This page may combine multiple inventors who share the name “LI DERUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
15 patentsUS11028092B2Jun 8, 2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
MERCK SHARP & DOHME2 citations73
US10934294B2Mar 2, 2021
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors
MERCK SHARP & DOHME2 citations72
US9527875B2Dec 27, 2016
Antidiabetic tricyclic compounds
MERCK SHARP & DOHME4 citations71
US10414774B2Sep 17, 2019
Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
MERCK SHARP & DOHME1 citations61
US10995085B2May 4, 2021
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME1 citations60
US11319283B2May 3, 2022
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations51
US11208407B2Dec 28, 2021
Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations51
US11111232B2Sep 7, 2021
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations51
US11034661B2Jun 15, 2021
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
MERCK SHARP & DOHME0 citations51
US10988487B2Apr 27, 2021
Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations51
US10927086B2Feb 23, 2021
Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations51
US11498904B2Nov 15, 2022
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations50
US10647705B2May 12, 2020
Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME0 citations50
US11274111B2Mar 15, 2022
Arginase inhibitors and methods of use
MERCK SHARP & DOHME0 citations48
US10414775B2Sep 17, 2019
Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
MERCK SHARP & DOHME0 citations37
MERCK SHARP & DOHME LLC
8 patentsUS12030872B2Jul 9, 2024
N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC2 citations69
US12065438B2Aug 20, 2024
Substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors
MERCK SHARP & DOHME LLC0 citations51
US12275729B2Apr 15, 2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
MERCK SHARP & DOHME LLC0 citations49
US12215116B2Feb 4, 2025
Arginase inhibitors and methods of use
MERCK SHARP & DOHME LLC0 citations49
US12319671B2Jun 3, 2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations48
US12240867B2Mar 4, 2025
Arginase inhibitors and methods of use
MERCK SHARP & DOHME LLC0 citations48
US12570640B2Mar 10, 2026
2-aminoquinazolines as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
MERCK SHARP & DOHME LLC0 citations46
US12440496B2Oct 14, 2025
Natriuretic peptide receptor a agonists useful for the treatment of cardiometabolic diseases, kidney disease and diabetes
MERCK SHARP & DOHME LLC0 citations45